PubRank

Rüdiger Waldherr

Author PubWeight™ 41.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006 5.29
2 Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010 3.48
3 Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006 1.82
4 Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002 1.78
5 Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002 1.44
6 Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation. Ann Hematol 2007 1.44
7 Acute renal failure due to a malignant lymphoma infiltration uncovered by renal biopsy. Nephrol Dial Transplant 2004 1.42
8 Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002 1.24
9 Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 2007 1.10
10 Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 2011 1.10
11 Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 2008 0.97
12 An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 2003 0.94
13 Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. Am J Physiol Renal Physiol 2009 0.93
14 IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up. Transpl Int 2012 0.93
15 Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis. J Leukoc Biol 2003 0.91
16 Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 2002 0.90
17 Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversible. Nephron 2002 0.90
18 Frequency of kidney disease in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003 0.87
19 Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 2006 0.85
20 IgA nephropathy and hodgkin's disease: a rare coincidence. Case report and literature review. Am J Kidney Dis 2005 0.85
21 N-octanoyl-dopamine is an agonist at the capsaicin receptor TRPV1 and mitigates ischemia-induced [corrected] acute kidney injury in rat. PLoS One 2012 0.84
22 15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2005 0.84
23 In renal transplants with delayed graft function chemokines and chemokine receptor expression predict long-term allograft function. Transplantation 2010 0.84
24 SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits. Kidney Int 2003 0.83
25 Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy. J Hepatol 2005 0.83
26 Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption. Transplantation 2015 0.82
27 Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. J Mol Med (Berl) 2008 0.81
28 An unusual manifestation of Wegener's granulomatosis in a 4-year-old girl. Pediatr Neurol 2002 0.80
29 No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement. Nephrol Dial Transplant 2003 0.80
30 A cutaneous disease with multisystem involvement: hypomelanosis of Ito may be associated with proteinuria, focal segmental glomerulosclerosis and end-stage renal disease. Nephrol Dial Transplant 2007 0.79
31 Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol 2002 0.79
32 Acute kidney injury in a patient with melanuria, diffuse melanosis, and metastatic malignant melanoma. Am J Clin Dermatol 2008 0.79
33 The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection. Transpl Int 2013 0.78
34 Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome. Pediatr Nephrol 2007 0.78
35 The patient with C-ANCA/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment. Nephrol Dial Transplant 2008 0.77
36 Vagal stimulation in brain dead donor rats decreases chronic allograft nephropathy in recipients. Nephrol Dial Transplant 2013 0.77
37 Cellular infiltrates and NFκB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance. Transplantation 2012 0.77
38 Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 2005 0.77
39 N-Octanoyl Dopamine for Donor Treatment in a Brain-death Model of Kidney and Heart Transplantation. Transplantation 2015 0.77
40 Does borderline kidney allograft rejection always require treatment? Transplantation 2010 0.76
41 Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. Nephrol Dial Transplant 2006 0.76
42 Dialysis-associated acquired cystic kidney disease imitating autosomal dominant polycystic kidney disease in a patient receiving long-term peritoneal dialysis. Nephrol Dial Transplant 2002 0.76
43 SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity. Pediatr Transplant 2006 0.75
44 Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi. Transpl Int 2015 0.75
45 Donor Desmopressin Treatment Does Not Affect Transplant Outcome in the Fischer to Lewis Rat Renal Transplant Model. Exp Clin Transplant 2016 0.75
46 A generalized seizure in a renal allograft recipient. Nephrol Dial Transplant 2005 0.75
47 Lymphoid interstitial lung disease in a patient with acute tubulointerstitial nephritis and uveitis: a new facet of a rare syndrome? Am J Kidney Dis 2006 0.75
48 Treatment of proteinuria with low-molecular-weight heparin after renal transplantation. Transpl Int 2004 0.75
49 Atorvastatin donor pre-treatment in a model of brain death and allogeneic kidney transplantation in rat. Ann Transplant 2012 0.75
50 Late recovery of renal function by rituximab in a patient with Wegener's granulomatosis. Pediatr Nephrol 2012 0.75
51 Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis--is it the only cause? Nephrol Dial Transplant 2007 0.75
52 Is the sauna a common place for experiencing acute renal failure? Nephrol Dial Transplant 2005 0.75